Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 414,000 | 865,000 | 928,000 | 1,925,000 | 1,734,000 |
| Receivables | 2,558,000 | 2,228,000 | 1,970,000 | 1,778,000 | 1,531,000 |
| Inventories | 2,810,000 | 2,484,000 | 1,867,000 | 1,610,000 | 1,351,000 |
| Other current assets | 831,000 | 622,000 | 731,000 | 799,000 | 1,884,000 |
| TOTAL | $6,920,000 | $6,514,000 | $5,760,000 | $6,317,000 | $6,694,000 |
| Non-Current Assets | |||||
| PPE Net | 3,294,000 | 2,859,000 | 2,446,000 | 2,252,000 | 2,084,000 |
| Intangibles | 23,773,000 | 20,390,000 | 18,822,000 | 18,109,000 | 15,868,000 |
| Other Non-Current Assets | 5,409,000 | 5,372,000 | 5,442,000 | 5,552,000 | 6,131,000 |
| TOTAL | $32,476,000 | $28,621,000 | $26,710,000 | $25,913,000 | $24,083,000 |
| Total Assets | $39,395,000 | $35,136,000 | $32,469,000 | $32,229,000 | $30,777,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,778,000 | 531,000 | 20,000 | 261,000 | 13,000 |
| Accounts payable and accrued liabilities | 960,000 | 942,000 | 862,000 | 794,000 | 513,000 |
| Accrued Expenses | 2,773,000 | 2,646,000 | 2,160,000 | 2,436,000 | 2,197,000 |
| Other current liabilities | 887,000 | 814,000 | 761,000 | 783,000 | 958,000 |
| TOTAL | $6,399,000 | $4,933,000 | $3,803,000 | $4,274,000 | $3,681,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,968,000 | 8,571,000 | 8,915,000 | 8,804,000 | 9,130,000 |
| Other Non-Current Liabilities | 1,878,000 | 1,968,000 | 2,035,000 | 2,220,000 | 2,309,000 |
| TOTAL | $10,993,000 | $10,672,000 | $11,094,000 | $11,334,000 | $11,769,000 |
| Total Liabilities | $17,392,000 | $15,606,000 | $14,896,000 | $15,607,000 | $15,451,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,475,778 | 1,467,096 | 1,434,780 | 1,426,725 | 1,417,166 |
| Common Shares | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 |
| Retained earnings | 2,673,000 | 819,000 | -750,000 | -1,392,000 | -2,378,000 |
| Other shareholders' equity | 508,000 | 298,000 | 268,000 | 262,000 | 206,000 |
| TOTAL | $22,003,000 | $19,530,000 | $17,573,000 | $16,622,000 | $15,326,000 |
| Total Liabilities And Equity | $39,395,000 | $35,136,000 | $32,469,000 | $32,229,000 | $30,777,000 |